Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 03/23

Trade details

Type
Insider sale
Amount
$1,440,970.82
Shares · price
2,749 sh · $524.18 a share
Held after
45,166 sh
Trade date
26/03/20
Filed
26/03/23
Days to filing
3 days

Sold 5.7% of holdings

Share of holding sold
5.7%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 02/18~04/19

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $262.3K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $1.4M of United Therapeutics UTHR · 5.7% of holdings · 10b5-1 plan | Whalegun